We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$439B
AUM Growth
+$49B
Cap. Flow
+$65.7B
Cap. Flow %
14.98%
Top 10 Hldgs %
33.97%
Holding
14,356
New
1,622
Increased
5,458
Reduced
5,222
Closed
1,858

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$703M
2
TSLA icon
Tesla
TSLA
+$585M
3
JPM icon
JPMorgan Chase
JPM
+$582M
4
AMZN icon
Amazon
AMZN
+$566M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$466M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$349M
2
HD icon
Home Depot
HD
+$334M
3
TMUS icon
T-Mobile US
TMUS
+$270M
4
CI icon
Cigna
CI
+$258M
5
CDW icon
CDW
CDW
+$237M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Healthcare 2.55%
3 Financials 2.39%
4 Consumer Discretionary 2.14%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCMI icon
12176
National CineMedia
NCMI
$269M
$11K ﹤0.01%
1,725
-21,214
-92% -$256K
PHGE icon
12177
BiomX
PHGE
$1.59M
$11K ﹤0.01%
+168
New +$21.4K
PRFX icon
12178
PRF Technologies Ltd
PRFX
$3.13M
$11K ﹤0.01%
+13
New +$11.7K
VVOS icon
12179
CALL
Vivos Therapeutics
VVOS
$4.77M
$11K ﹤0.01%
692
-164
-19% -$5K
BYNOW
12180
DELISTED
byNordic Acquisition Corporation Warrant
BYNOW
$11K ﹤0.01%
138,421
-141,174
-50% -$14.3K
CFFSW
12181
DELISTED
CF Acquisition Corp. VII Warrant
CFFSW
$11K ﹤0.01%
95,771
-99
-0.1% -$11
CYTO
12182
CALL
DELISTED
Altamira Therapeutics Ltd
CYTO
$11K ﹤0.01%
98
-2
-2% -$332
ZYNE
12183
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$11K ﹤0.01%
14,400
-2,200
-13% -$2.5K
ARDS
12184
CALL
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$11K ﹤0.01%
11,800
+1,400
+13% +$2.18K
HEXO
12185
PUT
DELISTED
HEXO Corp. Common Shares
HEXO
$11K ﹤0.01%
4,407
-1,264
-22% -$3.6K
SEAC
12186
PUT
DELISTED
Seachange International Inc
SEAC
$11K ﹤0.01%
1,315
+20
+2% +$215
OIG
12187
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$11K ﹤0.01%
591
-1,617
-73% -$44.8K
OIG
12188
PUT
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$11K ﹤0.01%
555
-1,268
-70% -$35.2K
ASPU
12189
DELISTED
ASPEN GROUP, INC.
ASPU
$11K ﹤0.01%
+29,896
New +$25.9K
AMPE
12190
CALL
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$11K ﹤0.01%
622
-169
-21% -$5.92K
ADVM
12191
PUT
DELISTED
Adverum Biotechnologies
ADVM
$10K ﹤0.01%
1,070
-40
-4% -$526
ADXN
12192
Addex Therapeutics
ADXN
$10K ﹤0.01%
+640
New +$14.3K
AKBA icon
12193
PUT
Akebia Therapeutics
AKBA
$242M
$10K ﹤0.01%
32,500
+6,400
+25% +$2.51K
BBAI.WS icon
12194
BigBear.ai Holdings Warrant
BBAI.WS
$38.5M
$10K ﹤0.01%
67,017
-3,230
-5% -$615
SRXH
12195
SRX Global
SRXH
$37.5M
$10K ﹤0.01%
6
-13
-68% -$46.3K
CARM
12196
DELISTED
Carisma Therapeutics
CARM
$10K ﹤0.01%
+1,155
New +$15.7K
CETX icon
12197
Cemtrex
CETX
$5.2M
0
CRVS icon
12198
CALL
Corvus Pharmaceuticals
CRVS
$1.25B
$10K ﹤0.01%
12,300
-13,100
-52% -$12.5K
OTRK
12199
PUT
DELISTED
Ontrak
OTRK
$10K ﹤0.01%
+247
New +$17.3K
GRCE
12200
Grace Therapeutics
GRCE
$45.4M
$10K ﹤0.01%
+2,971
New +$14.6K

Similar funds

Ken Griffin's Q3 2022 Portfolio in Review

As of Q3 2022, Ken Griffin held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ken Griffin deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.

  • Ken Griffin's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
  • Ken Griffin added most to Apple in Q3 2022, an estimated $703M increase.
  • Ken Griffin's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
  • Ken Griffin fully exited Regions Financial in Q3 2022, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
  • Ken Griffin opened 1,622 new positions and closed 1,858 in Q3 2022.
  • Ken Griffin's portfolio value rose 13% quarter-over-quarter to $439B.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.